Millennium pandemic: A Review of coronavirus disease (COVID-19)

Basit Öğe Kaydı
dc.contributor.authorBilgin, Satılmış
dc.contributor.authorKurtkulağı, Özge
dc.contributor.authorKahveci, Gizem Bakir
dc.contributor.authorDuman, Tuba T.
dc.contributor.authorTel, Burçin Meryem Atak
dc.date.accessioned2021-06-23T18:27:21Z
dc.date.available2021-06-23T18:27:21Z
dc.date.issued2020
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractCoronaviruses, a large family of single-stranded RNA viruses, can infect humans and animals, and can cause neurological, gastrointestinal and hepatic diseases as well as causing various lung diseases, including pneumonia, with shortness of breath, cough and fever. At the end of December 2019, a group of health authorities reported unidentified cases of pneumonia in a seafood market in Wuhan, China. The World Health Organization (WHO) used term 2019 novel coronavirus (COVID-19) to refer to a coronavirus that affected the lower respiratory tract of patients with pneumonia in Wuhan, China on 29 December and the WHO announced that the official name of the 2019 novel coronavirus was coronavirus disease (COVID-19). COVID-19 is seen in many countries around the World and has been accepted as a pandemic by WHO. It is defined as a suspicious case with fever, sore throat, cough, and people with a history of traveling to China or some parts of the country, or someone who contact with a patient who has a history of travel in China or contact with a confirmed COVID-19 infection patient. Currently, there is no proven vaccine or antiviral therapy that can be used against animal or human coronavirus. To control the outbreak, the drugs must be developed as soon as possible. Various drugs have been used in the treatment of COVID-19 and the main ones are chloroquine, remdesivir, lopinavir/ritonavir, oseltamivir, favipiravir. Since the virus affects the whole World, vaccines and/or new curative antiviral drugs are needed to end the pandemic. For this purpose, large-scale observational studies are needed.en_US
dc.identifier.doi10.30714/j-ebr.2020259176
dc.identifier.endpage125en_US
dc.identifier.issn2618-6454
dc.identifier.issn2618-6454
dc.identifier.issue2en_US
dc.identifier.startpage117en_US
dc.identifier.trdizinid366007en_US
dc.identifier.urihttps://doi.org/10.30714/j-ebr.2020259176
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TXpZMk1EQTNOdz09
dc.identifier.urihttps://hdl.handle.net/20.500.12491/1646
dc.identifier.volume3en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.institutionauthorBilgin, Satılmış
dc.institutionauthorKurtkulağı, Özge
dc.institutionauthorKahveci, Gizem Bakir
dc.institutionauthorDuman, Tuba T.
dc.institutionauthorTel, Burçin Meryem Atak
dc.language.isoenen_US
dc.relation.ispartofExperimental Biomedical Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject2019-nCoV
dc.subjectCOVID-19
dc.subjectCoronavirus
dc.subjectEpidemiology
dc.subjectPneumonia
dc.subjectTreatment
dc.subjectPandemic
dc.titleMillennium pandemic: A Review of coronavirus disease (COVID-19)en_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
satilmis-bilgin.pdf
Boyut:
1.08 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin/ Full text
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu